OBJECTIVE: Nutrition plays an important role in metabolic syndrome etiology. We examined whether the Women's Health Initiative (WHI) Dietary Modification Trial influenced metabolic syndrome risk. MATERIALS/ METHODS:48,835 postmenopausal women aged 50-79 years were randomized to a low-fat (20% energy from fat) diet (intervention) or usual diet (comparison) for a mean of 8.1 years. Blood pressure, waist circumference and fasting blood measures of glucose, HDL-cholesterol and triglycerides were measured on a subsample (n=2816) at baseline and years 1, 3 and 6 post-randomization. Logistic regression estimated associations of the intervention with metabolic syndrome risk and use of cholesterol-lowering and hypertension medications. Multivariate linear regression tested associations between the intervention and metabolic syndrome components. RESULTS: At year 3, but not years 1 or 6, women in the intervention group (vs. comparison) had a non-statistically significant lower risk of metabolic syndrome (OR=0.83, 95%CI 0.59-1.18). Linear regression models simultaneously modeling the five metabolic syndrome components revealed significant associations of the intervention with metabolic syndrome at year 1 (p<0.0001), but not years 3 (p=0.19) and 6 (p=0.17). Analyses restricted to intervention-adherent participants strengthened associations at years 3 (p=0.05) and 6 (p=0.06). Cholesterol-lowering and hypertension medication use was 19% lower at year 1 for intervention vs. comparison group women (OR=0.81, 95% CI 0.60-1.09).Over the entire trial, fewer intervention vs. comparison participants used these medications (26.0% vs. 29.9%), although results were not statistically significant (p=0.89). CONCLUSIONS: The WHI low-fat diet may influence metabolic syndrome risk and decrease use of hypertension and cholesterol-lowering medications. Findings have potential for meaningful clinical translation.
RCT Entities:
OBJECTIVE: Nutrition plays an important role in metabolic syndrome etiology. We examined whether the Women's Health Initiative (WHI) Dietary Modification Trial influenced metabolic syndrome risk. MATERIALS/ METHODS: 48,835 postmenopausal women aged 50-79 years were randomized to a low-fat (20% energy from fat) diet (intervention) or usual diet (comparison) for a mean of 8.1 years. Blood pressure, waist circumference and fasting blood measures of glucose, HDL-cholesterol and triglycerides were measured on a subsample (n=2816) at baseline and years 1, 3 and 6 post-randomization. Logistic regression estimated associations of the intervention with metabolic syndrome risk and use of cholesterol-lowering and hypertension medications. Multivariate linear regression tested associations between the intervention and metabolic syndrome components. RESULTS: At year 3, but not years 1 or 6, women in the intervention group (vs. comparison) had a non-statistically significant lower risk of metabolic syndrome (OR=0.83, 95%CI 0.59-1.18). Linear regression models simultaneously modeling the five metabolic syndrome components revealed significant associations of the intervention with metabolic syndrome at year 1 (p<0.0001), but not years 3 (p=0.19) and 6 (p=0.17). Analyses restricted to intervention-adherent participants strengthened associations at years 3 (p=0.05) and 6 (p=0.06). Cholesterol-lowering and hypertension medication use was 19% lower at year 1 for intervention vs. comparison group women (OR=0.81, 95% CI 0.60-1.09).Over the entire trial, fewer intervention vs. comparison participants used these medications (26.0% vs. 29.9%), although results were not statistically significant (p=0.89). CONCLUSIONS: The WHI low-fat diet may influence metabolic syndrome risk and decrease use of hypertension and cholesterol-lowering medications. Findings have potential for meaningful clinical translation.
Authors: Barbara V Howard; J David Curb; Charles B Eaton; Charles Kooperberg; Judith Ockene; John B Kostis; Mary Pettinger; Aleksandar Rajkovic; Jennifer G Robinson; Jacques Rossouw; Gloria Sarto; James M Shikany; Linda Van Horn Journal: Am J Clin Nutr Date: 2010-02-17 Impact factor: 7.045
Authors: Lesley F Tinker; Denise E Bonds; Karen L Margolis; JoAnn E Manson; Barbara V Howard; Joseph Larson; Michael G Perri; Shirley A A Beresford; Jennifer G Robinson; Beatriz Rodríguez; Monika M Safford; Nanette K Wenger; Victor J Stevens; Linda M Parker Journal: Arch Intern Med Date: 2008-07-28
Authors: Angela Kong; Marian L Neuhouser; Liren Xiao; Cornelia M Ulrich; Anne McTiernan; Karen E Foster-Schubert Journal: Nutr Res Date: 2009-11 Impact factor: 3.315
Authors: Marcella E Rumawas; James B Meigs; Johanna T Dwyer; Nicola M McKeown; Paul F Jacques Journal: Am J Clin Nutr Date: 2009-10-14 Impact factor: 7.045
Authors: Susan J van Dijk; Edith J M Feskens; Marieke B Bos; Dianne W M Hoelen; Rik Heijligenberg; Mechteld Grootte Bromhaar; Lisette C P G M de Groot; Jeanne H M de Vries; Michael Müller; Lydia A Afman Journal: Am J Clin Nutr Date: 2009-10-14 Impact factor: 7.045
Authors: Georges AbouRjaili; Norbert Shtaynberg; Robert Wetz; Thomas Costantino; George S Abela Journal: Metabolism Date: 2010-01-08 Impact factor: 8.694
Authors: K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith Journal: Circulation Date: 2009-10-05 Impact factor: 29.690
Authors: Li Jiao; Liang Chen; Donna L White; Lesley Tinker; Rowan T Chlebowski; Linda V Van Horn; Peter Richardson; Dorothy Lane; Haleh Sangi-Haghpeykar; Hashem B El-Serag Journal: J Natl Cancer Inst Date: 2018-01-01 Impact factor: 13.506
Authors: Meghan B Skiba; Lindsay N Kohler; Tracy E Crane; Elizabeth T Jacobs; Aladdin H Shadyab; Ikuko Kato; Linda Snetselaar; Lihong Qi; Cynthia A Thomson Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-08-27 Impact factor: 4.254
Authors: Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Cynthia A Thomson; JoAnn E Manson; Michael S Simon; Barbara V Howard; Thomas E Rohan; Linda Snetselar; Dorothy Lane; Wendy Barrington; Mara Z Vitolins; Catherine Womack; Lihong Qi; Lifang Hou; Fridtjof Thomas; Ross L Prentice Journal: J Clin Oncol Date: 2017-06-27 Impact factor: 44.544
Authors: Kathy Pan; Aaron K Aragaki; Marian L Neuhouser; Michael S Simon; Juhua Luo; Bette Caan; Linda Snetselaar; Joanne E Mortimer; JoAnn E Manson; Candyce Kroenke; Dorothy Lane; Kerryn Reding; Thomas E Rohan; Rowan T Chlebowski Journal: Br J Cancer Date: 2021-05-18 Impact factor: 7.640
Authors: Alexi Vasbinder; Lesley F Tinker; Marian L Neuhouser; Mary Pettinger; Lauren Hale; Chongzhi Di; Oleg Zaslavsky; Laura L Hayman; Xioachen Lin; Charles Eaton; Di Wang; Ashley Scherman; Marcia L Stefanick; Wendy E Barrington; Kerryn W Reding Journal: Am J Clin Nutr Date: 2021-03-11 Impact factor: 7.045
Authors: Yuan Yuan; Kathy Pan; Joanne Mortimer; Rowan T Chlebowski; Juhua Luo; Jessica E Yan; Susan E Yost; Candyce H Kroenke; Lucile Adams-Campbell; Rami Nassir; Yangbo Sun; Aladdin H Shadyab; Mara Z Vitolins; Nazmus Saquib; Robert A Wild; JoAnn E Manson; Rebecca A Nelson Journal: Cancer Date: 2021-01-21 Impact factor: 6.921